Dr. Peter M. Farrugia, MD

Dr. Farrugia practices at Advanced Heart and Vascular of Central Jersey in Colts Neck, New Jersey.

Dr. Farrugia's NPI, 1003142530, was assigned on October 17, 2009. Dr. Farrugia graduated from State University of New York at Stony Brook, School of Medicine in 2004. Dr. Farrugia holds New Jersey license 25MA08938500.

Dr. Farrugia's primary practice is Advanced Heart and Vascular of Central Jersey, at 340 State Highway 34, Colts Neck, NJ 07722 in Monmouth County. The practice phone is (732) 487-3636.

Dr. Farrugia's primary practice is Advanced Heart and Vascular of Central Jersey in Colts Neck, New Jersey. Dr. Farrugia is also affiliated with Riverview Medical Center. The medical group on file is Advanced Heart and Vascular of Central Jersey. Dmand AI also links Dr. Farrugia to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farrugia practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Farrugia's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Farrugia is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Farrugia is licensed in New Jersey.

CMS data shows 4,726 Medicare services from Dr. Farrugia across 32 procedure codes in 2024, for 271 Medicare patients. Medicare paid $1,012,527 for them. Every service was in an office.

CMS counts 271 Medicare patients who saw Dr. Farrugia in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Farrugia's median patient age at 69, with 43% women.

In 2024, Dr. Farrugia wrote 383 Medicare Part D claims for 108 patients. 85% of them were for generic drugs. CMS names the drug for 283 of them, across 14 drugs with 11 or more claims each, at $40,691 in total drug cost. In 2023, CMS named 390 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Farrugia for performance year 2024, reported as part of a group. Dr. Farrugia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Farrugia as offering telehealth. CMS counts 76 procedures of leg revascularization (restoring blood flow) by Dr. Farrugia, more than 97% of the clinicians it reports for that procedure.

CMS Open Payments shows 761 general payments to Dr. Farrugia from 46 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. Inari Medical, Inc. paid the most, $460,961.

Dr. Farrugia graduated from State University of New York at Stony Brook, School of Medicine in 2004.